APR 30, 2014
Cornea/External Disease, Refractive Mgmt/Intervention
Avellino Lab USA has introduced the Avellino DNA Dual Test for LASIK Safety, which can detect two genetic mutations that cause post-LASIK complications, Avellino corneal dystrophy (ACD) and granular corneal dystrophy type I (GCD1).
"We have been utilizing the Avellino DNA Test for LASIK Safety since its availability in the United States, and it has been a fantastic tool for both our physicians and patients in increasing their confidence prior to LASIK," said Tom Tooma, MD, founder of NVISION Laser Eye Center. "Now, with the Avellino DNA Dual Test, patients can go into treatment knowing they are even more protected from adverse outcomes, such as loss of vision."
GCD1 features small translucent granules that form slowly in the layers of the cornea. Patients with GCD1 who undergo LASIK, LASEK or PRK are at an elevated risk of blindness.
The test involves a mouth swab, which is sent to Avellino Lab, a certified molecular diagnostic testing lab. Results are provided to the physician within 24 to 48 hours.